GB9311507D0 - Antibody fragments - Google Patents

Antibody fragments

Info

Publication number
GB9311507D0
GB9311507D0 GB939311507A GB9311507A GB9311507D0 GB 9311507 D0 GB9311507 D0 GB 9311507D0 GB 939311507 A GB939311507 A GB 939311507A GB 9311507 A GB9311507 A GB 9311507A GB 9311507 D0 GB9311507 D0 GB 9311507D0
Authority
GB
United Kingdom
Prior art keywords
antibody fragments
fragments
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939311507A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Inc
Original Assignee
Therapeutic Antibodies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutic Antibodies Inc filed Critical Therapeutic Antibodies Inc
Priority to GB939311507A priority Critical patent/GB9311507D0/en
Publication of GB9311507D0 publication Critical patent/GB9311507D0/en
Priority to ES94917087T priority patent/ES2108460T3/en
Priority to NZ266838A priority patent/NZ266838A/en
Priority to JP7501460A priority patent/JP2953782B2/en
Priority to US08/256,155 priority patent/US6193969B1/en
Priority to US08/256,053 priority patent/US5733742A/en
Priority to RU96101193A priority patent/RU2139092C1/en
Priority to DK94917088T priority patent/DK0703925T3/en
Priority to EP94917088A priority patent/EP0703925B1/en
Priority to CA002163032A priority patent/CA2163032C/en
Priority to AU68525/94A priority patent/AU6852594A/en
Priority to ES94917088T priority patent/ES2138662T3/en
Priority to EP94917087A priority patent/EP0701571B1/en
Priority to EP98203383A priority patent/EP0916678A3/en
Priority to PCT/GB1994/001209 priority patent/WO1994029347A1/en
Priority to PCT/GB1994/001210 priority patent/WO1994029348A2/en
Priority to AT94917087T priority patent/ATE157100T1/en
Priority to AU68524/94A priority patent/AU678483B2/en
Priority to DE69420137T priority patent/DE69420137T2/en
Priority to AT94917088T priority patent/ATE183513T1/en
Priority to DK94917087.2T priority patent/DK0701571T3/en
Priority to DE69405102T priority patent/DE69405102T2/en
Priority to GB9524064A priority patent/GB2294267B/en
Priority to NO954643A priority patent/NO954643D0/en
Priority to FI955798A priority patent/FI955798A/en
Priority to GR970402765T priority patent/GR3025133T3/en
Priority to GR990402504T priority patent/GR3031415T3/en
Pending legal-status Critical Current

Links

GB939311507A 1993-06-03 1993-06-03 Antibody fragments Pending GB9311507D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GB939311507A GB9311507D0 (en) 1993-06-03 1993-06-03 Antibody fragments
GB9524064A GB2294267B (en) 1993-06-03 1994-06-03 Anti-TNFalpha Fab fragments derived from polyclonal IgG antibodies
EP94917087A EP0701571B1 (en) 1993-06-03 1994-06-03 Antibody fragments in therapy
PCT/GB1994/001209 WO1994029347A1 (en) 1993-06-03 1994-06-03 Antibody fragments in therapy
JP7501460A JP2953782B2 (en) 1993-06-03 1994-06-03 Therapeutic antibody fragments
US08/256,155 US6193969B1 (en) 1993-06-03 1994-06-03 Antibody fragments in therapy
US08/256,053 US5733742A (en) 1993-06-03 1994-06-03 Production of antibody fragments from whole blood
RU96101193A RU2139092C1 (en) 1993-06-03 1994-06-03 Use of antibody fragment in therapy
DK94917088T DK0703925T3 (en) 1993-06-03 1994-06-03 Preparation of antibody fragments
EP94917088A EP0703925B1 (en) 1993-06-03 1994-06-03 Production of antibody fragments
CA002163032A CA2163032C (en) 1993-06-03 1994-06-03 Antibody fragments in therapy
AU68525/94A AU6852594A (en) 1993-06-03 1994-06-03 Production of antibody fragments
ES94917088T ES2138662T3 (en) 1993-06-03 1994-06-03 PRODUCTION OF ANTIBODY FRAGMENTS.
ES94917087T ES2108460T3 (en) 1993-06-03 1994-06-03 FRAGMENTS OF ANTIBODIES IN THERAPEUTICS.
EP98203383A EP0916678A3 (en) 1993-06-03 1994-06-03 Method of clotting blood
NZ266838A NZ266838A (en) 1993-06-03 1994-06-03 Treatment of patients with anti-tnfalpha antibody, antibody fragment
PCT/GB1994/001210 WO1994029348A2 (en) 1993-06-03 1994-06-03 Production of antibody fragments
AT94917087T ATE157100T1 (en) 1993-06-03 1994-06-03 ANTICODEPERFRAGMENTS IN THERAPY
AU68524/94A AU678483B2 (en) 1993-06-03 1994-06-03 Antibody fragments in therapy
DE69420137T DE69420137T2 (en) 1993-06-03 1994-06-03 PRODUCTION OF ANTIBODY FRAGMENTS
AT94917088T ATE183513T1 (en) 1993-06-03 1994-06-03 PREPARATION OF ANTIBODY FRAGMENTS
DK94917087.2T DK0701571T3 (en) 1993-06-03 1994-06-03 Antibody fragments for therapy
DE69405102T DE69405102T2 (en) 1993-06-03 1994-06-03 ANTIBODY FRAGMENTS IN THERAPY
NO954643A NO954643D0 (en) 1993-06-03 1995-11-17 Antibody fragment as well as the use and method of preparing the same
FI955798A FI955798A (en) 1993-06-03 1995-12-01 Therapeutic antibody fragments
GR970402765T GR3025133T3 (en) 1993-06-03 1997-10-22 Antibody fragments in therapy
GR990402504T GR3031415T3 (en) 1993-06-03 1999-10-07 Production of antibody fragments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939311507A GB9311507D0 (en) 1993-06-03 1993-06-03 Antibody fragments

Publications (1)

Publication Number Publication Date
GB9311507D0 true GB9311507D0 (en) 1993-07-21

Family

ID=10736608

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939311507A Pending GB9311507D0 (en) 1993-06-03 1993-06-03 Antibody fragments

Country Status (1)

Country Link
GB (1) GB9311507D0 (en)

Similar Documents

Publication Publication Date Title
DE69400639D1 (en) Rehydratationsgetraenk
DE69401926D1 (en) Hydroxamsäurederivate
DE69406448D1 (en) Luftreinigungsgerät
DE69405713D1 (en) Carbonylierungsverfahren
GB9412166D0 (en) Retargetting antibodies
DE69412242D1 (en) Orthopädisches gussmaterial
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
DE59409705D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
GB9314802D0 (en) Modified proteins
DE59408644D1 (en) Jacquardmaschine
DE69408437D1 (en) Oxychlorierungsverfahren
DE59408733D1 (en) Metallhalogenidentladungslampe
DE59410065D1 (en) 3-methoxy-2-phenyl-acrylsäuremethylester
DE69412128D1 (en) Kühlcontainer
DE69410761D1 (en) Polyacetalharzzusammensetzung
DE69407946D1 (en) Oxychlorierungskatalysator
DE69413832D1 (en) Amidierungskatalysatorkonzentrat
DE59407310D1 (en) Phenylazotriazolopyridinfarbstoffe
GB9311507D0 (en) Antibody fragments
AU122479S (en) Label-printer
DE69327259D1 (en) Signalmetrikabschätzer
GB9402593D0 (en) Antibody fragments
GB9320508D0 (en) Antibodies
GB9309884D0 (en) Antibodies
DE59403125D1 (en) Hohlleitermultiplexer/-demultiplexer